• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

I-tech

74.00 SEK+5.11 %21/8 17:29
Less than 1K followers

ITECH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+5.11 %
+9.14 %
+15.63 %
+60.17 %
+41.76 %
-35.65 %
+80.05 %
+23.33 %
+200.02 %

I-tech operates in marine technology. The company conducts research and development of substances that inhibit marine fouling on ship hulls. In addition, the products can be used for various marine installations in fish farming and offshore. Customers are found in the marine paint industry and among other players in the shipping industry. I-Tech was founded in 2000 and has its headquarters in Mölndal.

Read more
Market cap
887.84M SEK
Turnover
11.51M SEK
Revenue
168.12M
EBIT %
24.41 %
P/E
26.43
Dividend yield-%
1.69 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
16/10
2026

Interim report Q3'26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release2026-08-21 10:16

Investor Studios: Ledningen i I-Tech presenterar kvartalet live 13.00

I-tech
Third party research2026-08-21 09:22

I-tech: Strongest quarter on record - ABG

Sales +21% vs. ABGSCe, EBIT SEK 21m vs. ABGSCe 13m Easy comps, but +91% organic growth still very strong Gross margin held at 59%; raw-material pressure mitigated so far Q2 results I-tech reported very strong Q2 numbers. Sales came in at SEK 59m (+21...

I-tech
Regulatory press release2026-08-21 08:00

I-Tech AB (publ) (ticker ITECH) publicerar härmed sin Q2 halvårsrapport 2026

I-tech

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-08-21 08:00

I-Tech AB (publ) (ticker: ITECH) publish the Q2 half-year report for 2026

I-tech
Press release2026-08-19 10:00

I-Tech förvärvar rättigheter till biologiskt framställd antifoulingteknologi och breddar portföljen av hållbara lösningar

I-tech
Press release2026-08-19 10:00

I-Tech acquires rights to biologically derived antifouling technology to expand sustainable solutions portfolio

I-tech
Third party research2026-07-16 11:59

I-tech: Smooth sailing into easy comps - ABG

* Q2e: +58% organic growth, EBIT SEK 13m (5m) * Easy comps: customer with financial constraints not in Q2'25 base * Trading at '26e-'28e EV/EBIT 11x-5x, ~40-60% below peers Q2 expectations We estimate Q2 sales of SEK 48m, +53% y-o-y (+58% organic, -5...

I-tech
Press release2026-06-09 11:18

Analyst Group: Analyst Group intervjuar I-Techs VD Markus Jönsson

I-tech
Regulatory press release2026-05-21 17:42

Kommuniké från årsstämman 2026 i i-tech AB (publ)

I-tech
Regulatory press release2026-05-21 17:42

Report from the Annual General Meeting 2026 of i-tech AB (publ)

I-tech
Press release2026-05-20 14:00

Förändring i valberedningens styrelseförslag inför årsstämman i I‑Tech AB

I-tech
Press release2026-05-20 14:00

Change to the Board nomination proposal ahead of I‑Tech AB’s Annual General Meeting

I-tech
Third party research2026-05-08 08:28

I-tech: 2026 looking better than feared - ABG

* Q1: Organic growth of +7% despite tough comps (vs. ABGSCe -15%) * Customer with financial constraints back to normal order cadence * We raise organic growth ests. for '26e to +25% (+15% previously) Q1 results Q1 sales were much stronger than we expected...

I-tech
Press release2026-05-07 10:02

Investor Studios: Ledningen i I-Tech presenterar kvartalet live 13.00

I-tech
Third party research2026-05-07 09:05

I-tech: Significant beat across the PL - ABG

* Sales +27% vs. ABGSCe, EBIT SEK 19m vs. ABGSCe 9.8m * A beat on all line items, despite very tough comps * Gross margin 60% (56% LY), though may soften on raw material prices Much stronger growth than expected Sales came in above expectations at SEK...

I-tech
Regulatory press release2026-05-07 08:00

I-Tech AB (publ) (ticker ITECH) publicerar härmed sin delårsrapport för Q1 2026

I-tech
Regulatory press release2026-05-07 08:00

I-Tech AB (publ) (ticker: ITECH) publish the interim report for Q1 2026

I-tech
Third party research2026-05-05 12:43

I-tech: Announce extension of Selektope until Dec '26 - ABG

* Approval for Selektope extended again, now until Dec '26 * Ongoing process could not be finalised within timeframe * I-Tech views this as positive; invests in new EOGRT study Approval extended again, until Dec '26 The European Commission and the Standing...

I-tech
Press release2026-05-05 11:46

EU förlänger godkännandet för Selektope® till och med den 31 december 2026

I-tech
Press release2026-05-05 11:46

EU extends approval for Selektope® until 31 December 2026

I-tech